2026 Q1 Portfolio Activity
In 2026 Q1, EQT Fund Management S.a r.l. maintained a portfolio of 5 distinct positions. The most significant new addition was AGOMAB THERAPEUTICS NV, now representing 5.28% of the total fund value.
Position History
hover any row below to update
Loading…
Total Positions
5
Quarter
2026 Q1
Top Holding
WAY (58.8%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-5 of 5
EQT Fund Management S.a r.l. Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
WAY
WAYSTAR HLDG CO...
|
Healthcare | 58.77% | 73.27% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
24,879,437 | $599,843,226 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
OCS
OCULIS HOLDING ...
|
Healthcare | 15.37% | 10.60% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
5,900,294 | $156,888,817 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
EVMN
EVOMMUNE INC
|
Healthcare | 11.10% | 7.59% |
#3
1
Prev: #4
|
6.0 |
—
|
no change | no change |
P
S
|
4,929,633 | $113,332,263 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 9.48% | 8.55% |
#4
1
Prev: #3
|
5.3 |
—
|
no change | no change |
P
S
|
3,424,609 | $96,745,204 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
N/A
AGOMAB THERAPEU...
|
|
Unknown | 5.28% | — |
#5
Prev: #—
|
6.1 |
—
|
5,141,992 | — |
NEW
|
5,141,992 | $53,939,496 | — | 13F Filing | 2026-03-31 | 2026-05-14 |
Showing 1-5 of 5 holdings